Intact Type I Interferon Receptor Signaling Prevents Hepatocellular Necrosis but Not Encephalitis in a Dose-Dependent Manner in Rift Valley Fever Virus Infected Mice
Authors:
- Lukas Mathias MichaelyLMLukas Mathias Michaely
- Lukas SchuwerkLSLukas Schuwerk
- Lisa AllnochLALisa Allnoch
- Kathleen SchönKSKathleen Schön
- Inken WaltlIWInken Waltl
- Pia-Katharina LarsenPLPia-Katharina Larsen
- Andreas PavlouAPAndreas Pavlou
- Chittappen Kandiyil PrajeethCPChittappen Kandiyil Prajeeth
- Guus F. RimmelzwaanGRGuus F. Rimmelzwaan
- Stefanie C. BeckerSBStefanie C. Becker
- Ulrich KalinkeUKUlrich Kalinke
- Wolfgang BaumgärtnerWBWolfgang Baumgärtner
Open Access
- 18 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12492
Abstract
Rift Valley fever (RVF) is a zoonotic and emerging disease, caused by the RVF virus (RVFV). In ruminants, it leads to “abortion storms” and enhanced mortality rates in young animals, whereas in humans it can cause symptoms like severe hemorrhagic fever or encephalitis. The role of the innate and adaptive immune response in disease initiation and progression is still poorly defined. The present study used the attenuated RVFV strain clone 13 to investigate viral spread, tissue tropism, and histopathological lesions after intranasal infection in C57BL/6 wild type (WT) and type I interferon (IFN-I) receptor I knockout (IFNAR−/−) mice. In WT mice, 104 PFU RVFV (high dose) resulted in a fatal encephalitis, but no hepatitis 7–11 days post infection (dpi), whereas 103 PFU RVFV (low dose) did not cause clinical disease or significant histopathological lesions in liver and the central nervous system (CNS). In contrast, IFNAR−/− mice infected with 103 PFU RVFV developed hepatocellular necrosis resulting in death at 2–5 dpi and lacked encephalitis. These results show that IFNAR signaling prevents systemic spread of the attenuated RVFV strain clone 13, but not the dissemination to the CNS and subsequent fatal disease. Consequently, neurotropic viruses may be able to evade antiviral IFN-I signaling pathways by using the transneuronal instead of the hematogenous route.Keywords
Funding Information
- DFG Research Training Group 2485 VIPER
- Stiftung Tierärztliche Hochschule Hannover
- Alexander von Humboldt-Stiftung
- CEPI-funded project (LARISSA)
This publication has 69 references indexed in Scilit:
- HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infectionNature Communications, 2013
- Aerosol Exposure to Rift Valley Fever Virus Causes Earlier and More Severe Neuropathology in the Murine Model, which Has Important Implications for Therapeutic DevelopmentPLOS Neglected Tropical Diseases, 2013
- Heparan Sulfate Facilitates Rift Valley Fever Virus Entry into the CellJournal of Virology, 2012
- The Pathogenesis of Rift Valley FeverViruses, 2011
- The pathogenesis of Rift Valley fever virus in the mouse modelVirology, 2010
- Nonstructural NSs Protein of Rift Valley Fever Virus Interacts with Pericentromeric DNA Sequences of the Host Cell, Inducing Chromosome Cohesion and Segregation DefectsJournal of Virology, 2010
- Dual Functions of Rift Valley Fever Virus NSs Protein: Inhibition of Host mRNA Transcription and Post‐transcriptional Downregulation of Protein Kinase PKRAnnals of the New York Academy of Sciences, 2009
- NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein KinaseJournal of Virology, 2009
- Rift Valley Fever Virus NSs Protein Promotes Post-Transcriptional Downregulation of Protein Kinase PKR and Inhibits eIF2α PhosphorylationPLOS Pathogens, 2009
- TFIIH Transcription Factor, a Target for the Rift Valley Hemorrhagic Fever VirusCell, 2004